HomeCompareHBPCF vs NOBL

HBPCF vs NOBL: Dividend Comparison 2026

HBPCF yields 115.61% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HBPCF wins by $7.21M in total portfolio value
10 years
HBPCF
HBPCF
● Live price
115.61%
Share price
$1.73
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.23M
Annual income
$2,676,132.53
Full HBPCF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — HBPCF vs NOBL

📍 HBPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHBPCFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HBPCF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HBPCF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HBPCF
Annual income on $10K today (after 15% tax)
$9,826.59/yr
After 10yr DRIP, annual income (after tax)
$2,274,712.65/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, HBPCF beats the other by $2,274,503.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HBPCF + NOBL for your $10,000?

HBPCF: 50%NOBL: 50%
100% NOBL50/50100% HBPCF
Portfolio after 10yr
$3.63M
Annual income
$1,338,189.35/yr
Blended yield
36.90%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HBPCF buys
0
NOBL buys
0
No recent congressional trades found for HBPCF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHBPCFNOBL
Forward yield115.61%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$7.23M$22.8K
Annual income after 10y$2,676,132.53$246.19
Total dividends collected$6.55M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: HBPCF vs NOBL ($10,000, DRIP)

YearHBPCF PortfolioHBPCF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$22,261$11,560.69$10,914$214.34+$11.3KHBPCF
2$47,870$24,051.31$11,897$218.63+$36.0KHBPCF
3$99,558$48,337.27$12,952$222.72+$86.6KHBPCF
4$200,481$93,953.00$14,086$226.62+$186.4KHBPCF
5$391,330$176,815.76$15,302$230.33+$376.0KHBPCF
6$741,281$322,558.19$16,607$233.85+$724.7KHBPCF
7$1,364,208$571,036.96$18,007$237.18+$1.35MHBPCF
8$2,441,853$982,150.40$19,508$240.35+$2.42MHBPCF
9$4,255,766$1,642,983.32$21,116$243.35+$4.23MHBPCF
10$7,229,802$2,676,132.53$22,841$246.19+$7.21MHBPCF

HBPCF vs NOBL: Complete Analysis 2026

HBPCFStock

Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Full HBPCF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this HBPCF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HBPCF vs SCHDHBPCF vs JEPIHBPCF vs OHBPCF vs KOHBPCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.